White House pulls Heidi Overton's FDA nomination ahead of Senate committee vote
Photo: AP / STATThe White House pulled Dr. Heidi Overton's nomination to lead the Food and Drug Administration on Tuesday, a day before the Senate committee was scheduled to vote on whether to advance her — after questions emerged about whether she had the votes to win confirmation.
A White House official confirmed the decision to USA TODAY on November 17. The move was first reported by Axios. The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote on Wednesday, November 18, on whether to send her nomination to the full Senate.
With Democrats expected to oppose her, Overton needed unanimous Republican support on the 21-member committee to advance. Republicans hold a one-vote advantage on the panel, leaving the nomination vulnerable to a single GOP defection, according to Reuters, which cited three people familiar with the matter.
Sen. Bill Cassidy, the Louisiana Republican who chairs the committee, maintained Tuesday night that she was on the verge of garnering enough support. "Tonight, the White House abandoned a viable confirmation path for Dr. Overton," Cassidy wrote in a post on X shortly after her nomination was pulled. The White House did not immediately comment on Cassidy's contention.
Overton serves as deputy director of the White House Domestic Policy Council and previously worked at the America First Policy Institute, a conservative think tank. President Donald Trump nominated her in August, tapping a White House policy aide to lead an agency that has faced controversies over vaccines, drug approvals and abortion-related policy. She earned her medical degree from the University of New Mexico, trained in general surgery at Johns Hopkins and pursued clinical-investigation research training at the Johns Hopkins Bloomberg School of Public Health.
Her nomination followed the departure of former FDA Commissioner Marty Makary in May. Kyle Diamantas, the FDA's deputy commissioner for food, has led the agency as acting commissioner since Makary's departure.
Overton faced sharp questioning from senators during a confirmation hearing in September over vaccine policy and whether she would keep politics out of FDA decision-making. Cassidy, a doctor, pressed her to affirm the safety of the measles, mumps and rubella (MMR) vaccine and criticized her support for a Trump-backed plan to split the childhood vaccination schedule into additional doses. Democrats also scrutinized her anti-abortion views; Overton had called the Supreme Court's 2022 decision overturning Roe v. Wade "a huge victory for life." Oversight of the abortion pill mifepristone became a focal point of the hearing, and she drew criticism over her alleged ties to tobacco interests, her support for vaping and her anti-abortion stance.
Overton is just the latest health care nominee to be pulled amid crumbling Republican support; the White House has also yanked nominees to lead the Centers for Disease Control and Prevention and the surgeon general's office. The withdrawal is now likely to leave the FDA without a permanent leader well into next year. The agency has faced significant upheaval during Trump's second term, including declining morale following workforce cuts across the Health and Human Services Department ordered by Secretary Robert F. Kennedy Jr. The FDA has lost more than 3,000 employees over the past year, including senior leaders. CNN also reported a strained relationship between Overton and Kennedy.
The White House is now searching for a new nominee to lead the FDA, a key health agency overseeing the regulation of prescription drugs, vaccines, medical devices and food safety. According to Reuters, the White House is weighing outgoing Kansas Sen. Roger Marshall — who lost his re-election bid earlier this month and chairs the Senate's Make America Healthy Again caucus — as a possible replacement.
Sources: USA TODAY, "White House pulls Heidi Overton's FDA nomination ahead of Senate panel vote" (Nov. 17, 2026, full text verified); CNN, "White House drops Trump's FDA pick amid senators' opposition and 'icy' relationship with RFK Jr." (Nov. 17, 2026); Reuters, "Trump withdraws Heidi Overton as nominee to lead Food and Drug Administration, sources say" (Nov. 17, 2026); AP via Scripps News Group / TMJ4, "White House pulls FDA nominee after wavering support from Senate Republicans" (Nov. 17, 2026).
Sponsored
